Search results for "Gout"
Continue BP control, maintain benefits
Helping patients maintain normal blood pressure over the long haul pays off in cardiovascular and other health benefits, yet studies show that U.S. adults continue to backslide.
https://immattersacp.org/archives/2024/05/continue-bp-control-maintain-benefits.htm
1 May 2024
Serum urate level may predict flare risk in patients with gout
Approximately 95% of acute gout episodes requiring treatment occurred in patients who had a serum urate level of at least 6 mg/dL at baseline while 98% occurred in those with a baseline level of at least 5 mg/dL, according to a study using UK Biobank data on 1,773 episodes over a mean follow-up of 8.3 years.
https://immattersacp.org/weekly/archives/2024/02/13/1.htm
13 Feb 2024
SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout
New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://immattersacp.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023
New gout guidelines and 'treat to target'
Guidelines by ACP and by rheumatology societies disagree on the treat-to-target approach to therapy.
https://immattersacp.org/archives/2017/04/gout.htm
1 Apr 2017
Allopurinol not associated with increased mortality in patients with CKD, gout
The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/09/spotlight.htm
1 Sep 2023
Gout flares may precede cardiovascular events
A retrospective study found that gout patients who experienced an acute myocardial infarction or stroke had significantly higher odds of a recent gout flare in the preceding four months than those who did not.
https://immattersacp.org/weekly/archives/2022/08/09/1.htm
9 Aug 2022
Guideline recommends allopurinol as first-line therapy for gout
The American College of Rheumatology noted that the drug is the preferred choice for urate-lowering therapy in all patients, including those with moderate to severe chronic kidney disease.
https://immattersacp.org/weekly/archives/2020/05/19/4.htm
19 May 2020
Statins, gout guidelines fuel debate on best practice
This issue covers the debate about statins guidelines, evidence-based guidelines for gout, and physicians-in-training who face discrimination.
https://immattersacp.org/archives/2017/04/editors.htm
1 Apr 2017
SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists
In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://immattersacp.org/weekly/archives/2020/01/14/2.htm
14 Jan 2020